If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.16m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Offer for Subscription

8 Feb 2021 09:56

RNS Number : 3062O
Maven Income & Growth VCT PLC
08 February 2021
 

Maven Income and Growth VCT PLC (the Company)

 

Offer for Subscription

 

8 February 2021

 

On 23 October 2020, the Company and Maven Income and Growth VCT 5 PLC announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

 

The Board is pleased to advise that, with valid subscriptions received to date under the Company's Offer now approaching its initial fundraising target of £10 million, and in view of continued interest from potential investors, the Directors have resolved to utilise the over-allotment facility, as provided for under the terms and conditions of the Offers, to the extent required to meet further investor demand.

 

The deadline for receipt of applications for the Offers is 12.00 noon on 30 March 2021 in relation to the tax year 2020/21 and 12.00 noon on 30 April 2021 in relation to the tax year 2021/22. The Offers will close on 4 May 2021 unless the relevant Offer is fully subscribed by an earlier date or extended by the relevant Board to no later than 6 October 2021.

 

Downloadable versions of the Prospectus documents are available at: www.mavencp.com/vctoffer.

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com 

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKVLBBFLLEBBX
Date   Source Headline
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM
7th Jun 20234:21 pmRNSAnnual Financial Report
2nd Jun 20239:39 amRNSIssue of Equity
1st Jun 202312:18 pmRNSNet Asset Value(s)
26th May 20233:53 pmRNSTransaction in Own Shares
24th May 202310:52 amRNSUnaudited NAV and Proposed Final Dividend
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
5th Apr 202312:33 pmRNSDirector/PDMR Shareholding
5th Apr 202312:26 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
3rd Mar 202310:37 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 20239:47 amRNSIssue of Equity
21st Feb 20234:39 pmRNSTransaction in Own Shares
6th Feb 20234:23 pmRNSNet Asset Value(s)
2nd Dec 20229:30 amRNSIssue of Equity
25th Nov 202212:36 pmRNSStatement re Dividend Investment Scheme
9th Nov 20222:34 pmRNSResult of General Meeting
4th Nov 202211:15 amRNSHalf-year Report
26th Oct 20223:50 pmRNSTransaction in Own Shares
14th Oct 20223:33 pmRNSNet Asset Value and Interim Dividend
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
5th Aug 20224:39 pmRNSTransaction in Own Shares
15th Jul 202211:08 amRNSIssue of Equity
11th Jul 20223:12 pmRNSStatement re Dividend Investment Scheme
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
8th Jul 20222:36 pmRNSNet Asset Value(s)
7th Jul 20222:34 pmRNSResult of AGM
8th Jun 20222:12 pmRNSAnnual Financial Report
29th Apr 20222:28 pmRNSTransaction in Own Shares
27th Apr 20224:04 pmRNSTransaction in Own Shares
21st Apr 202211:22 amRNSStatement re NAV and Proposed Final Dividend
25th Jan 20224:04 pmRNSTransaction in Own Shares
21st Jan 20223:15 pmRNSNet Asset Value(s)
3rd Dec 20219:48 amRNSIssue of Equity
26th Nov 20219:53 amRNSStatement re Dividend Investment Scheme
12th Nov 20214:31 pmRNSHalf-year Report
11th Nov 20214:23 pmRNSTransaction in Own Shares
9th Nov 20211:33 pmRNSTransaction in Own Shares
27th Oct 20214:44 pmRNSNet Asset Value and Interim Dividend
20th Sep 20214:57 pmRNSStatement re Change of Registrar
16th Jul 202110:04 amRNSIssue of Equity
12th Jul 20214:28 pmRNSStatement re Dividend Investment Scheme
7th Jul 20213:32 pmRNSNet Asset Value(s)
7th Jul 202112:37 pmRNSResult of AGM
4th Jun 20214:16 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.